Guardant Health
GH
#1137
Rank
ยฃ16.01 B
Marketcap
ยฃ119.33
Share price
-4.17%
Change (1 day)
139.01%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -ยฃ2.52

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.50. In 2025 the company made an earnings per share (EPS) of -ยฃ2.45 an increase over its 2024 EPS that were of -ยฃ2.63.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ2.522.94%
2025-ยฃ2.45-7.02%
2024-ยฃ2.63-16.82%
2023-ยฃ3.16-33.13%
2022-ยฃ4.7360%
2021-ยฃ2.9655.04%
2020-ยฃ1.91207.14%
2019-ยฃ0.62-19.81%
2018-ยฃ0.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-ยฃ2.07-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ1.83-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA